| 药物共晶技术中国专利申请状况分析 |
| |
| 引用本文： | 毛丹. 药物共晶技术中国专利申请状况分析[J]. 中国药科大学学报, 2015, 46(4): 509-512. DOI: 10.11665/j.issn.1000-5048.20150421 |
| |
| 作者姓名： | 毛丹 |
| |
| 作者单位： | 1.国家知识产权局专利局专利审查协作江苏中心 |
| |
| 摘 要： | 药物共晶是药物活性成分和共晶形成物以氢键或其他非共价键结合形成的晶体，近年来有关药物共晶的研究已成为药物研发的新热点。本文从专利申请状况、专利申请人、专利申请的法律状态、专利申请的技术等角度进行分析，为药物共晶研究提供研究方向。
|
| 关 键 词： | 药物共晶 专利 实证分析 研发建议 伊潘立酮 |
Patent analysis of pharmaceutical cocrystals technology in China |
| |
| MAO Dan. Patent analysis of pharmaceutical cocrystals technology in China[J]. Journal of China Pharmaceutical University, 2015, 46(4): 509-512. DOI: 10.11665/j.issn.1000-5048.20150421 |
| |
| Authors: | MAO Dan |
| |
| Abstract: | Pharmaceutical cocrystals are formed from the active pharmaceutical ingredients and cocrystal formers through hydrogen bonding or other noncovalent bonds, which have attracted much attention in pharmaceutical field in recent years. From the analysis of patent application situation, patent applicant, legal status, and patent application techniques, guiding directions for the future research and development of the pharmaceutical cocrystals are proposed in this article. |
| |
| Keywords: | pharmaceutical cocrystals patent empirical analysis suggestion iloperidone |
|
| 点击此处可从《中国药科大学学报》浏览原始摘要信息 |
|
点击此处可从《中国药科大学学报》下载免费的PDF全文 |
